Splenectomy for thrombocytopenia in chronic granulocytic leukemia

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2010

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

Annals of oncology : official journal of the European Society for Medical Oncology·2007

Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2003

Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.

Annals of oncology : official journal of the European Society for Medical Oncology·2001

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.

Cancer·2001

Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001

Beyond risk factors: A capacity framework for cancer survivorship research.

Cancer·2026

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Cancer·2026

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement.

Cancer·2026

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Cancer·2026

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Cancer·2026

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

Cancer·2026

Prevalence of Alloimmunization Among Patients With Transfusion-Dependent Thalassemia and Sickle Cell Disease in Salmaniya Medical Complex, Bahrain.

Cureus·2026

A Study on the Clinical Phenotypes and Genetic Analysis of ENG Variants in Four Hereditary Hemorrhagic Telangiectasia Type 1 Families.

Human mutation·2026

HLA One-Way Mismatch as a Definitive Risk Factor for Graft-versus-Host Disease and Mortality in Living Donor Liver Transplantation.

Transplantation proceedings·2026

Does Tranexamic acid fix all bleeding in surgery?

Journal of the National Medical Association·2026

Allele and haplotype frequencies in high-resolution typing of human leukocyte antigen -A,-B, -C, -DRB1, and -DQB1 in 263,542 Thai voluntary stem cell donors.

Human immunology·2026

Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.

Clinical pharmacokinetics·2026

Related Experiment Videos

Splenectomy for thrombocytopenia in chronic granulocytic leukemia

Related Concept Videos

End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.

Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.

Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants.

Beyond risk factors: A capacity framework for cancer survivorship research.

Blinatumomab administration in the outpatient setting: Safety and health care utilization.

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement.

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis.

Prevalence of Alloimmunization Among Patients With Transfusion-Dependent Thalassemia and Sickle Cell Disease in Salmaniya Medical Complex, Bahrain.

A Study on the Clinical Phenotypes and Genetic Analysis of ENG Variants in Four Hereditary Hemorrhagic Telangiectasia Type 1 Families.

HLA One-Way Mismatch as a Definitive Risk Factor for Graft-versus-Host Disease and Mortality in Living Donor Liver Transplantation.

Does Tranexamic acid fix all bleeding in surgery?

Allele and haplotype frequencies in high-resolution typing of human leukocyte antigen -A,-B, -C, -DRB1, and -DQB1 in 263,542 Thai voluntary stem cell donors.

Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.

Related Experiment Videos

Splenectomy for thrombocytopenia in chronic granulocytic leukemia

Related Concept Videos

Related Articles